MedTrace Logo

Influence of Probiotics on the Vaginal Microbiota

NCT04471116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-07-16

No results posted yet for this study

Summary

The study aims to assess the influence of a probiotic supplement (OMNi-BiOTiC® FLORA plus +) on the vaginal microbiome composition of women suffering from infertility.

Conditions

  • Vaginal Microbiome

Interventions

DIETARY_SUPPLEMENT

OMNi-BiOTiC® FLORA plus+

OMNi-BiOTiC® FLORA plus + is a dietary supplement for the treatment of a disturbed vaginal flora (dysbiosis). The product combines probiotic bacterial strains with a special fiber mixture. The product contains the following strains: Lactobacillus crispatus LBV88, Lactobacillus rhamnosus LBV96, Lactobacillus gasseri LBV150N and Lactobacillus jensenii LBV116

Sponsors & Collaborators

  • Institut AllergoSan

    collaborator UNKNOWN

  • Kinderwunsch Institut GmbH

    lead OTHER

Principal Investigators

  • Michael Schenk, MD · Kinderwunsch Institut GmbH

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-30
Primary Completion
2019-07-19
Completion
2019-11-12

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471116 on ClinicalTrials.gov